Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative 2014-12-05 00:53
1